Ledger.Open graph →
SEC Form D · filed September 27, 2024

CTRL Therapeutics USA, Inc

Offering
$10.0M
Sold
$9.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
GLENCOE, IL
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Derrell Porter · Glencoe, ILExec · DirectorCollin Todd · Glencoe, ILDirectorDavid O'Neill · New York, NYDirectorShana Kelley · Glencoe, ILExec · DirectorDerrell Porter · Glencoe, ILExec · DirectorCollin Todd · Glencoe, ILDirectorDavid O'Neill · Seattle, WADirectorShana Kelley · Glencoe, ILExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗